Triple

T15983530
Position Surface form Disambiguated ID Type / Status
Subject European medicines regulatory authorities E387633 entity
Predicate follows P134 FINISHED
Object Good Clinical Practice guidelines E131969 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Good Clinical Practice guidelines | Statement: [European medicines regulatory authorities, follows, Good Clinical Practice guidelines]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Good Clinical Practice guidelines
Context triple: [European medicines regulatory authorities, follows, Good Clinical Practice guidelines]
  • A. ICH E6 Good Clinical Practice chosen
    ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
  • B. ICH E8 General Considerations for Clinical Trials
    ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
  • C. ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
    ICH M3(R2) is an international guideline that harmonizes requirements for nonclinical safety studies needed to support the initiation and progression of human clinical trials and the marketing authorization of pharmaceuticals.
  • D. Good Manufacturing Practices
    Good Manufacturing Practices are a set of regulatory and industry standards that ensure products are consistently produced and controlled to quality and safety requirements, particularly in sectors like food, pharmaceuticals, and cosmetics.
  • E. GAC Principles and Guidelines
    GAC Principles and Guidelines are a set of policy frameworks and best-practice recommendations developed to guide governments’ participation and advice on public policy issues related to the global Domain Name System within ICANN.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da94ccc819083d187f5dc6a123e completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e15756d6488190ac35da00e96ce21d completed April 16, 2026, 9:40 p.m.
NED1 Entity disambiguation (via context triple) batch_69ffc3cdf7848190848e9081027dc027 completed May 9, 2026, 11:31 p.m.
Created at: April 10, 2026, 4:54 a.m.